News and Events
We recently had a new health-economic evaluation study accepted for publication in the Journal of Investigational Allergology and Clinical Immunology.
Our Market Analysis Unit published a new methodological paper on pricing.
We are now using IBM Watson to analyze health evidence & design better clinical trials & economic models. See for instance: GLOBMOD-Watson Optimal Treatment Choices
We are partnering with IBM and investing in Real World Evidence technology, expanding Trialyst - for simulation and dynamical management of clinical trials - and the Market Change Calculator project - for price optimization and segmentation.
Lorenzo Sabatelli took part in the scientific meeting "Running to Stand Still" organized by ISGlobal and Rothamsted Research, with funding from the Biotechnology and Biological Sciences Research Council (BBSRC, UK). The 3-day interdisciplinary meeting focused on resistance to drugs and herbicides, biological evolution, and treatment strategies.
Interested in metrics encompassing the impact of human activities on health and on the environment? Check out the LinkedIn post Metrics of Planetary Health.
Our economic evaluation of Fractional Exhaled Nitric Oxide (FENO) for the management of adult asthma in Spain will be presented at the European Respiratory Society International Congress. The study was commissioned by Aerocrine, a Swedish medical device company.
GLOBMOD has been selected to participate in the IBM Global Entrepreneur Program, and will be using IBM cloud resources to scale up services and research activities.
We have launched the MARKET CHANGE CALCULATOR a free online application to forecast the effect of price changes on consumer-demand and market revenues.
We are offering a new Artificial Intelligence Service, based on Machine Learning and Big Data technology, to identify patterns in patient outcomes and healthcare performance. Please contact us, if interested in discussing potential projects and collaborations.
Lorenzo Sabatelli and colleagues presented an economic evaluation of the use of the Bispectral Index Monitor (COVIDIEN) in the UK at the ISPOR 17th Annual European Congress, in Amsterdam.
The Open University of Catalonia asked Lorenzo Sabatelli: Will better health technology help us build a smarter world? Here you can find a few thoughts.
Lorenzo Sabatelli and colleagues will present an economic evaluation of the use of the Bispectral Index Monitor in the UK at the ISPOR 17th Annual European Congress, in Amsterdam this November.
The Open University of Catalonia asked Lorenzo Sabatelli to address the question Will better health technology help us build a smarter world? Here you can find a few thoughts.
Lorenzo Sabatelli will present GLOBMOD research in a Modelling session of the 10th World Congress of the International Health Economics Association, that will be held in Dublin on July 13-16.
We will be at the MIHealth Congress, on May 21-22, in Barcelona.
We are organizing a roundtable discussion on Big Data and Health. It will take place on May 7, from 18:00 to 19:30 at the Institut de Estadistica de Catalunya, in Barcelona, Spain.
In January 2014, we have launched a design-thinking service. We will contribute to design-thinking activities focusing on health, and help inventors and designers maximize the health and economic benefit associated with new e-health technologies.
On November 4, Dr. Lorenzo Sabatelli, GLOBMOD principal scientist, will deliver a podium presentation entitled: A Methodology for Predicting the Impact of Co-payments on the Utilization of Health Technologies, at the ISPOR 16th Annual European Congress, to be held in Dublin, Ireland.
On June 17, Dr. Lorenzo Sabatelli, GLOBMOD principal scientist, gave the talk: A Model Using Household-Income and Consumption Data to Estimate the Cost and Effectiveness of Subsidies within the session New Directions in Cost-Effectiveness Analysis, at the Global Health Metrics and Evaluation Conference 2013, in Seattle (WA).
March 2013. The abstract A Method to Estimate Disease-Stage-Specific Survival Using Data Obtained from a Prevalent Cohort was accepted for presentation at the ISPOR 18th Annual International Meeting.
Is copper the solution to healthcare acquired infections? We helped the University of York appraise the evidence. Conclusions are theirs. The project was funded by the International Copper Association. Find out more.